Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.23 USD | +1.36% | -0.39% | 0.00% |
14/05 | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
09/05 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- CGON Stock
- News CG Oncology, Inc.
- Official Publications